ML-262 is an inhibitor of hepatic lipid droplet formation (IC50 = 6.4 nM in murine AML-12 cells), which is associated with non-alcoholic fatty liver disease. ML-262 does not induce cytotoxicity (up to 33 μM) or inhibit fatty acid uptake (up to 50 μM).

902502-82-3

C27H32N2O4S

480.62

ML-262

DMSO:25 mg/mL
DMSO:PBS (pH 7.2) (1:2):0.33 mg/mL
DMF:12.5 mg/mL
Powder: -20°C for 3 years
In solvent: -80°C for 2 years